Drug Usage Trend study

Antidyslipidemic drugs

Of the 14 branded antidyslipidemic drugs, Crestor had the highest usage rate at 83%, followed by Lipitor (78%) and Zetia (71%). For the rate of product awareness, the top 2 drugs were the same as usage rate, however Mevalotin had high awareness rate and it came to the 3rd. (See graph below) Future usage expectation was high for all products; Lotriga had the highest rate and followed by Caduet.
Also, 30% of the respondents have plans to start using a new product within the next six months.

  • Target samples: N=514 with internal medicine doctors, gastroenterologists, cardiologists, endocrinologists, nephrologists, and neurosurgeons
  • Study period: May ~ June 2014
  • Studied products: Mevalotin, Lipovas, Lochol, Lipitor, Livalo, Crestor, Lipidil, Tricor, Bezatol SR, Cholebine, Epadel, Lotriga, Zetia, Caduet
  • Studied items: average monthly number of patients and prescriptions, product awareness and usage rates, product satisfaction, the reasons for use, future usage expectations (short-term), intentions of switching, rate of not switching to generic products, and reasons for adopting new products
  • SSRI Drug Usage Trend study is a physician study that started in 1984, which focuses on products in various therapeutic areas